Background Histamine, released from mast cells in atheromatous plaque, has been known to cause cardiac ischemia or sudden cardiac death in atherosclerosis patient. Previous reports have suggested that histamine induced coronary vasoconstriction was due to increase in IP 3 and DAG, which induce release of Ca
sensitivity of contractile element via activation of PKC. Recently, it was reported that application of histamine cause depolarization of intestinal smooth muscle, which may contribute to histamineinduced contraction via augmenting Ca 2 influx through activation of Ca 2 channels. However, the underyling mechanism of histamine-induced depolarization and its contribution to the magnitude of coronary vasoconstriction are still uncertain. Method To elucidate the underlying mechanism of Ca 2 influx change during histamineinduced vasoconstriction, we examined the effect of Ca 2 channel antagonist and PKC blocker on histamineinduced contractions, and then measured the effect of PKC antagonist on whole cell K current using patch clamping method in rabbit coronary smooth muscle cells. Results Application of histamine induced phasic and tonic constraction of coronary rings via activation of H 1 receptors. Pretreatment of Ca 2 channel antagonist nifedipine, 1 M or PKC blockers 10 nM staurosporine and 10 M Gö6976 markedly inhibited histamineinduced tonic contraction, which suggest that the magnitude of tonic contraction depend on the Ca A) Time course of 1,2-DiC8-induced change of peak K + currents measured at 0 mV steps at every 10 seconds. Application of 1,2-DiC8 significantly decreased K + currents. The 1, 2, & 3 indicated the representative current traces of control, 1,2-DiC8, and recovery. B) Representative traces of whole cell currents during control, 1,2-DiC8 (10 μM), and after washout of 1,2-DiC8. K + currents were evoked by stepping the membrane potentials from a holding potential of -80 mV to potentials ranging from -50 mV to +25 mV in 5 mV increments. C) Average current voltage relations of peak currents in control (○), after 1,2-DiC8 (•) treatment (n＝6). The peak current amplitudes were normalized with whole cell capacitance. Application of 1,2-DiC8 signifi-cantly inhibited the K + currents (*：p<0.01).
고 안 ＋ currents measured at 0 mV steps at every 10 seconds. Application of 1,3-DiC8 slightly decreased K ＋ currents, whereas 1,2-DiC8 apparently decreased K ＋ currents. The 1, 2, & 3 indicated the representative current traces of control, 1,3-DiC8, and 1,2-DiC8. B) Representative traces of whole cell currents during control and after application of 1,3-DiC8 (10 μM), and 1,2-DiC8 (10 μM) in the bath. The current traces recorded during 195 ms step pulses from -50 mV to +25 mV in 5 mV increments. C) Average current voltage relations of peak currents in control (○), after 1,3-DiC8 (•) treatment (n＝4). The peak current amplitudes were normalized with whole cell capacitance.
Fig. 11. Inhibition of PKC-dependent change of voltage-dependent K
+ current by calphostin C. A) representative traces of whole cell currents during control and after application of calphostin C (1 μM), and 1,2-DiC8 (10 μM) in the bath. The current traces recorded during 195 ms step pulses from -50 mV to +25 mV in 5 mV increments. B) Average current voltage relations of peak currents in control (○), after calphostin C treatment (□), and calphostin C+1,2-DiC8 (■) treatment (n＝4). The peak current amplitudes were normalized with cell capacitance. C) Summary of voltage-dependent K + current amplitudes recorded at 0 mV steps. The current amplitudes were expressed as the percent of control current amplitudes. Cal-C and Cal-C+1,2-DiC8 represent calphostin C and calphostin C+1,2-DiC8 treatment, respectively. Pretreatment of calphostin C significantly attenuated the 1,2-DiC8-induced inhibition of K + current (1,2-DiC8 treated group vs calphostin C+1,2DiC8 treated group；59.4±1.9 vs 84.1±9.6% of control current amplitude*：p<0.05, n＝4). 
